← Back to home
Comparison · Analytics

OpenCTI vs pharmaverseadam

A side-by-side editorial comparison of OpenCTI and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.

OpenCTI vs pharmaverseadam: at a glance

FeatureOpenCTIpharmaverseadam
SectorAnalyticsAnalytics
Velocity score6.30.0
Sparks · 30d00
Top themesthreat-intelligence, stix, data-model, ingestionpharmaverse, clinical-data, adam, test-data
Last editorial update16h ago4d ago
WebsiteVisit →Visit →

What is OpenCTI?

OpenCTI spends a release unblocking queues and hardening upserts

7.260817.0 is a fix release. The most consequential item is malformed STIX messages nacking forever and blocking worker queues indefinitely — a stall in the ingestion path rather than a display bug. Alongside it: upsert clearing an existing createdBy when incoming confidence is higher, draft upserts crashing on existing attack patterns, OTP handling in the stream middleware, and case template relation authorization. Score fields were added to threat actor groups, intrusion sets and malware.

Read the full OpenCTI trajectory →

What is pharmaverseadam?

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

Read the full pharmaverseadam trajectory →

OpenCTI vs pharmaverseadam: editorial side-by-side

O
OpenCTI
ANALYTICS
6.3

OpenCTI spends a release unblocking queues and hardening upserts

◆ Current state

7.260817.0 is a fix release. The most consequential item is malformed STIX messages nacking forever and blocking worker queues indefinitely — a stall in the ingestion path rather than a display bug. Alongside it: upsert clearing an existing createdBy when incoming confidence is higher, draft upserts crashing on existing attack patterns, OTP handling in the stream middleware, and case template relation authorization. Score fields were added to threat actor groups, intrusion sets and malware.

◆ Where it's heading

The platform's feature energy went into the connector catalog and integrations rework in July, and the releases since have been consolidating: mass operations on relation times, shareable saved searches, and now a pass over ingestion robustness. Adding score to more entity types continues the slow enrichment of the data model that runs underneath the feature work.

◆ Prediction

Given score arriving on three entity types in one release, expect it to keep spreading across the data model, and the queue-blocking class of bug to draw more worker-side hardening.

P0.0

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

◆ Current state

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

◆ Where it's heading

Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.

◆ Prediction

Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.

Alternatives to OpenCTI and pharmaverseadam

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either OpenCTI or pharmaverseadam.

See all OpenCTI alternatives → · See all pharmaverseadam alternatives →

Recent activity from OpenCTI and pharmaverseadam

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1d agoOpenCTIMalformed STIX no longer blocks worker queues indefinitely
  2. 4d agoOpenCTILTS branch gets the security backport: access-scoped streams, dependency sweep
  3. 7d agoOpenCTIMass operations can now edit relation start and stop times
  4. 11d agoOpenCTISaved searches and dashboard filters become shareable and reusable
  5. 15d agoOpenCTIData sanity operations can be stopped mid-run
  6. 20d agoOpenCTIIntegrations experience reworked around the new catalog, plus draft approval workflows
  7. 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
  8. 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
  9. 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
  10. 2y agopharmaverseadam1.0 declares the dataset collection stable
  11. 2y agopharmaverseadamFirst release of the ADaM dataset collection

Frequently asked questions

What is the difference between OpenCTI and pharmaverseadam?

They serve adjacent needs but don't currently overlap on shipped themes. OpenCTI is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is OpenCTI better than pharmaverseadam?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. OpenCTI is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to OpenCTI?

Top OpenCTI alternatives in Analytics are ranked by recent ship velocity. Browse the "OpenCTI alternatives" section above for the current picks, or visit /alternatives/opencti for the full list with editorial commentary on each.

What are the best alternatives to pharmaverseadam?

Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.